In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
How did the Air India plane get stuck under the bridge?
You must have seen the plane flying in the sky, running on the runway, but rarely have you seen a
The National Testing Agency (NTA) has declared the result of the National Eligibility-cum-Entranc
AQI reached 336 due to increase in pollution, OPD up to 1500
AQI had reached 300 till 03 days ago, the dust rising on the roads is also increasing the trouble
In its latest World Economic Outlook report, the International Monetary Fund (IMF) has predicted
Given the increasing cases of dengue in the country, Union Health Minister Mansukh Mandaviya has
COP26 World Leaders' Summit: Prime Minister Narendra Modi has arrived in Glasgow to participate i
Corona cases have increased again in the country. The Health Ministry released a report on Thursd
For Prime Minister Narendra Modi's rally on Thursday, security arrangements have been tightened f
After Salman Khan and Shahrukh Khan, now Bhojpuri actress Akshara Singh has received death threat
There was a ruckus on Dravid's advice to Saha to retire, what is inside
The controversy of Wriddhiman Saha, who was the wicket-keeper batsman of the Indian team, is in t
